Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study
Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women
Patients Prefer Silicone Over Saline Implants
More Breast Cancer Patients Opt To Remove Both Breasts
Small Study: Radiation, Chemo May Better Control Anal Cancer
BRAF Inhibitor Shrank Tumors In Phase II Genentech Study
Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer
Radiotherapy Plus Cetuximab May Control Head/Neck Cancer
Clinical Trials Approved By NCI
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation
